New research out of the United Kingdom indicates that early screening for prostate cancer can lead to unnecessary treatment and nasty side-effects.
The conclusion comes from a 10-year randomized study at the University of Bristol. It focused on PSA testing involving more than 400,000 men aged 50 – 69. Men with a raised PSA level were invited to have a biopsy which is required to confirm a diagnosis.